Afanat 30mg Tablet
Prescription Required
Marketed By
Natco
Pack of
28
Salt Composition
Afatinib
Storage
Keep in cold place
₹3115₹3956.25
21.26% Off
Inclusive of all taxes
1
Afanat 30mg Tablet
Delivering To: —
All Substitutes
Overview
The active component of Afanat 30mg Tablet is afatinib dimaleate. Patients with non-small cell lung cancer (NSCLC) whose tumors include specific abnormal epidermal growth factor receptor (EGFR) genes, as well as those with metastatic, squamous NSCLC that progresses following platinum-based chemotherapy, are treated with this anticancer medication.
Indication
Lung Cancer
Reference
Cheema, P. K., Thawer, A., Leake, J., Cheng, S. Y., Khanna, S., & Charles Victor, J. (2024). Multi-disciplinary proactive follow-up algorithm for patients with advanced NSCLC receiving afatinib. Supportive Care in Cancer, 27(3), 1029-1039.
Harvey, R. D., Adams, V. R., Beardslee, T., & Medina, P. (2020). Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings. Journal of Oncology Pharmacy Practice, 26(6), 1461-1474.
Jin, H., Liang, P., Hou, J., Li, B., Wang, P., & He, X. (2023).The Efficacy and Safety of Afatinib in Non‐Small Cell Lung Cancer Patients with Brain Metastasis: A Meta‐Analysis. Journal of Oncology, (1), 5493725.
Lee, C. K., Wu, Y. L., Ding, P. N., Lord, S. J., Inoue, A., Zhou, C., & Yang, J. C. H. (2025). Impact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: a meta-analysis. Journal of Clinical Oncology, 33(17), 1958-1965.
Wu, S. G., Yu, C. J., Yang, J. C. H., & Shih, J. Y. (2020). The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation. Therapeutic Advances in Medical Oncology, 12.
Uses
Non-small cell lung cancer (NSCLC) and certain mutations of epidermal growth factor receptor (EGFR).
Benefits
Side Effects
Some of the common side effects of the Afanat 30 mg Tablet are:
Infection
Headache,
Fever
Loss of appetite
Rash
High blood pressure
Hair loss
lack of sleep.
Vomiting
Indigestion
Nausea
Constipation
How To Use
Afanat 30mg Tablet is taken once a day regularly at the same time each day to increase its effectiveness. It is an oral medication that can be taken with or without food. The capsules should not be chewed, opened, or crushed; they should be swallowed. Afanat 30mg Tablet should be taken as recommended by the doctor.
How It Works
Afanat 30mg Tablet inhibits or binds to the HER2, HER4, and EGFR enzyme receptors. It stops or slows the spread of cancer by downregulating signaling pathways.
Safety Advice
Alcohol
consult your doctor
Taking an Afanat 30 mg tablet while operating machinery may cause confusion or affect one's capacity to drive. The capsule may cause neurological side effects, such as fever or feeling dizzy. Until you feel better, don't drive
Pregnancy
consult your doctor
It is not advised to take the Afanat 30 mg Tablet regularly when pregnant; instead, it should be injected after speaking with the doctor. In cases of difficult, life-threatening situations, Afanat 30 mg Tablet can be administered. But it might affect the fetus.
Breast Feeding
consult your doctor
Because there is a possibility that the Afanat 30 mg Tablet could be transferred to the developing infant through the mother's breast milk, it is not advised to consume it while nursing. It is widely regarded as dangerous, and there is not enough evidence in the clinical data on its adverse impacts on infants
Driving
unsafe
Taking an Afanat 30 mg tablet while operating machinery may cause confusion or affect one's capacity to drive. The capsule may cause neurological side effects, such as fever or feeling dizzy. Until you feel better, don't drive.
Kidney
safe if prescribed
People with kidney issues can use the Afanat 30 mg Tablet after consulting with the doctor. It may harm the kidneys if taken on self-medication. The capsule contains afatinib, which belongs to a rare case of acute kidney injury (AKI)
Liver
safe if prescribed
People with mild to severe liver illness should not use the Afanat 30 mg tablet. Even so, the enzyme must be regularly monitored. Use caution and alter the dosage.
Missed Doses
Quick Tips
FAQs
No, Afanat 30mg Tablet is an anti-cancer medication (specifically a kinase inhibitor or targeted therapy drug) used to treat certain types of non-small cell lung cancer.
It is advised not to take alcohol while taking the Afanat 30 mg Tablet, because consuming alcohol can cause serious side effects and can damage your liver badly. Consult your doctor if you have concerns or queries.
As soon as you remember, take the missed dose unless it's time for your next dose. You should never take a double dose to make up for a missed one.
Common side effects of the Afanat 30 mg Tablet are constipation, muscle pain, swelling, nausea, diarrhea, infection, loss of appetite, hair loss, vomiting, and weakness.
The doctor decides how long the treatment with the Afanat 30 mg tablet will continue, depending on the stage and health of the patient.
During pregnancy, it is not safe to take Afanat 30 mg Tablet, as it can cause harm to the unborn baby. Furthermore, during breastfeeding, this medicine must not be used. Please make sure to consult your healthcare provider regarding the same
Afanat 30 mg Tablet works by inhibiting or binding with the enzyme receptors (EGFR, HER2, and HER4). It causes the downregulation of signaling pathways, stopping or slowing the spread of cancer.
Inform the doctor if you are allergic to the ingredient present in the Afanat 30 mg Tablet, in case of high sugar level, pregnancy or breastfeeding, or a weakened immune system. Patient with medical history or medication.
As the capsule suppresses the immune system, the risk of infection increases. Afanat 30 mg Tablet can increase the risk of getting cancer, such as lymph gland cancer (lymphoma) and skin cancer. It can lower the body's ability to fight infections.
Related Products
MARKETER DETAILS
Natco
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.